SCHEMBL15030736

SCHEMBL15030736

CCOP(C)(=O)N1CCN(C2CCNCC2)CC1

nearest known ligand 0.40

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
CHRM1 P11229 1/20 0.32
KHK P50053 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15443901 0.88 CHRM1 (0.35) TP53TDP1CHRM1KHK
SCHEMBL19981539 0.83 CHRM2 (0.33) CHRM1KHK
SCHEMBL15443789 0.80 TSHR (0.36) TP53TDP1
SCHEMBL14654986 0.80 MAPK1 (0.41) TP53TDP1CHRM1
SCHEMBL21316777 0.79 GNAO1 (0.36)
SCHEMBL14655015 0.78 MAPK1 (0.43) TP53TDP1CHRM1
SCHEMBL15443760 0.76 MEN1 (0.41) TP53TDP1CHRM1
SCHEMBL408996 0.72
SCHEMBL18993493 0.72
SCHEMBL15443801 0.71 TSHR (0.37) TP53TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2788487-B1 OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA SAREPTA THERAPEUTICS INC (US) 2018-04-04 EP disclosed
EP-2788488-B1 METHODS FOR TREATING PROGEROID LAMINOPATHIES USING OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA SAREPTA THERAPEUTICS INC (US) 2018-03-21 EP disclosed
US-9682097-B2 Oligonucleotide analogues targeting human LMNA SAREPTA THERAPEUTICS, INC. (US) 2017-06-20 US disclosed
WO-2013086444-A2 METHODS FOR TREATING PROGEROID LAMINOPATHIES USING OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA SAREPTA THERAPEUTICS, INC. (US) 2013-06-13 WO disclosed